Tilray Brands Files 8-K on Financials

Ticker: TLRY · Form: 8-K · Filed: 2025-01-10T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, 8-k

TL;DR

Tilray Brands dropped an 8-K on Jan 10th detailing financials - check it out.

AI Summary

Tilray Brands, Inc. filed an 8-K on January 10, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 655 Madison Avenue, New York, NY. Tilray Brands, Inc. was formerly known as Tilray, Inc. before a name change on February 13, 2018.

Why It Matters

This 8-K filing provides investors with updated information on Tilray Brands' financial performance and operational status, which is crucial for evaluating the company's current health and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any significant new risks or negative developments.

Key Players & Entities

Tilray Brands, Inc. (company) — Registrant
January 10, 2025 (date) — Date of earliest event reported
655 Madison Avenue, New York, NY (location) — Principal Executive Offices
Tilray, Inc. (company) — Former company name
February 13, 2018 (date) — Date of name change

FAQ

What specific financial information is being reported in this 8-K filing?

The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.

When was the earliest event reported in this filing?

The earliest event reported is dated January 10, 2025.

What is the principal executive office address for Tilray Brands, Inc.?

The principal executive offices are located at 655 Madison Avenue, 19th Floor, New York, NY 10065.

Has Tilray Brands, Inc. always been known by this name?

No, the company was formerly known as Tilray, Inc., with a name change occurring on February 13, 2018.

What is the SIC code for Tilray Brands, Inc.?

The Standard Industrial Classification code is 2833, for MEDICINAL CHEMICALS & BOTANICAL PRODUCTS.

From the Filing

0001171843-25-000152.txt : 20250110 0001171843-25-000152.hdr.sgml : 20250110 20250110070013 ACCESSION NUMBER: 0001171843-25-000152 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250110 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250110 DATE AS OF CHANGE: 20250110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray Brands, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 824310622 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 25520335 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Tilray, Inc. DATE OF NAME CHANGE: 20180213 8-K 1 f8k_011025.htm FORM 8-K Form 8-K 0001731348 False 0001731348 2025-01-10 2025-01-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________ FORM 8-K _________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):  January 10, 2025 _______________________________ Tilray Brands, Inc. (Exact name of registrant as specified in its charter) _______________________________ Delaware 001-38594 82-4310622 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 265 Talbot Street West Leamington , Ontario N8H 4H3 (Address of Principal Executive Offices) (Zip Code) ( 844 ) 845-7291 (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) _______________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.0001 per share TLRY The NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐     Item 2.02. Results of Operations and Financial Condition. On January 10, 2025, Tilray Brands, Inc. (“Tilray”) issued a press release announcing financial results for its second quarter ended November 30, 2024. A copy of the press release is furnished herewith as Exhibit 99.1. The information in this current report on Form 8-K, including the press release attached as Exhibit 99.1 hereto, is being furnished, but shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilitie